Document Detail


Effect of statins on collagen type I degradation in patients with coronary artery disease and atrial fibrillation.
MedLine Citation:
PMID:  18178406     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The present study was undertaken to assess the effect of statins on collagen type I degradation and C-reactive protein in patients with coronary artery disease and atrial fibrillation. One hundred six patients with coronary artery disease and atrial fibrillation were studied: 40 (36 men, mean age 72 +/- 8 years) treated with a statin and 66 (48 men, mean age 74 +/- 9 years) not treated with a statin. Serum concentrations of carboxy-terminal telopeptide of collagen type I, an index of collagen type I degradation, and high-sensitivity C-reactive protein were measured in all patients. Carboxy-terminal telopeptide of collagen type I levels were significantly higher (p <0.001) in statin-treated patients (0.64 ng/ml, 95% confidence interval [CI] 0.57 to 0.71) compared with nonstatin-treated patients (0.38 ng/ml, 95% CI 0.31 to 0.44). These changes were independent of cholesterol levels (before or after therapy). Statin-treated patients had significantly lower (p <0.001) C-reactive protein levels (0.25 mg/dl, 95% CI 0.23 to 0.28) compared to statin nonusers (1.1 mg/dl, 95% CI 0.92 to 1.25). In conclusion, this study suggests that therapy with statins in patients with coronary artery disease and atrial fibrillation is associated with an increase in collagen degradation and an attenuation of inflammation, independently of cholesterol lowering.
Authors:
Dimitrios N Tziakas; Georgios K Chalikias; Dimitrios A Stakos; Nikolaos Papanas; Sofia V Chatzikyriakou; Konstantina Mitrousi; Efstratios Maltezos; Harissios Boudoulas
Related Documents :
20233976 - Cognitive function and anticoagulation control in patients with atrial fibrillation.
6188126 - The induction of atrial flutter and fibrillation and the termination of atrial flutter ...
10522566 - Transvenous internal cardioversion for atrial fibrillation: a randomized study on defib...
16886886 - Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control.
22461446 - Cardiac torsion-strain relationships in fatigued primary biliary cirrhosis patients sho...
10826546 - Lactate dehydrogenase activity in pathological human tears obtained with glass capillar...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  The American journal of cardiology     Volume:  101     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2008 Jan 
Date Detail:
Created Date:  2008-01-07     Completed Date:  2008-02-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  199-202     Citation Subset:  AIM; IM    
Affiliation:
University Cardiology Department, Democritus University of Thrace, Alexandroupolis, Greece. dtziakas@med.duth.gr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Atrial Fibrillation / blood,  complications,  drug therapy*
C-Reactive Protein / metabolism*
Collagen Type I / blood*
Coronary Artery Disease / blood,  complications,  drug therapy*
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage,  therapeutic use*
Male
Treatment Outcome
Chemical
Reg. No./Substance:
0/Collagen Type I; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian populati...
Next Document:  Determinants of pacemaker dependency after coronary and/or mitral or aortic valve surgery with long-...